Literature DB >> 6770951

HLA and disease 1980.

.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6770951      PMCID: PMC1601620     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

Review 1.  Evolutionary significance of the HL-A system.

Authors:  W F Bodmer
Journal:  Nature       Date:  1972-05-19       Impact factor: 49.962

2.  Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type.

Authors:  H O McDevitt; A Chinitz
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

3.  HLA-B27, Klebsiella, and ankylosing spondylitis.

Authors:  A F Geczy; J Yap
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

4.  Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations.

Authors:  A Svejgaard; L P Ryder
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

5.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

Review 6.  HL-A and disease associations--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder; L S Nielsen; M Thomsen
Journal:  Transplant Rev       Date:  1975

7.  A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component.

Authors:  A F Geczy; K Alexander; H V Bashir; J Edmonds
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

8.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

9.  Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  B Dupont; S E Oberfield; E M Smithwick; T D Lee; L S Levine
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.